Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Titan Pharma: How High Will It Go on Probuphine News?
Seeking Alpha
Thursday, June 2, 2011 - 1:35pm
tags:
Titan, Probuphine
North Carolina Preemption Bill Is Closer To Reality
Pharmalot
Thursday, June 2, 2011 - 10:56am
tags:
preemption, North Carolina
FDA gives fast-track status to Tioga irritable bowel drug
San Diego Union Tribune, CA
Thursday, June 2, 2011 - 10:47am
tags:
irritable bowel syndrome, FDA, IBS, Tioga, fast track
Teva begins new double-dose Copaxone trial
Globes, Israel
Thursday, June 2, 2011 - 10:45am
tags:
Teva Pharmaceuticals, Copaxone, MS, multiple sclerosis
Pfizer, Zhejiang Hisun May Form Generics Venture For China Market
WSJ Online
Thursday, June 2, 2011 - 10:42am
tags:
Pfizer, Zhejiang Hisun, generics, China
Merck CEO Frazier stands by his $8B R&D gamble
Fierce Biotech
Thursday, June 2, 2011 - 10:40am
tags:
Merck, Kenneth Frazier, Pharma CEOs, R&D
Teva eyes deals in India, gets US OK for generic Aricept
Pharma Times, UK
Thursday, June 2, 2011 - 10:39am
tags:
India, Teva Pharmaceuticals, generics, Aricept
Aastrom Biosciences' Trial Meets Safety and Efficacy Endpoints
Seeking Alpha
Thursday, June 2, 2011 - 10:35am
tags:
Aastrom
Ziopharm seeks lower cancer drug prices
Reuters
Thursday, June 2, 2011 - 10:33am
tags:
Ziopharm, cancer, drug pricing
How Lilly Blundered With Amylin: Kliff Explains
Pharmalot
Thursday, June 2, 2011 - 10:31am
tags:
Amylin, Eli Lilly
Filling an Unmet Need: A Look at Generex and RXI Pharma's Breast Cancer Vaccines
Seeking Alpha
Thursday, June 2, 2011 - 10:30am
tags:
breast cancer, vaccines, Generex, RXi Pharmaceuticals, NeuVax
Careful Analysis Reveals Good Probability Large of Gains for Vical
Seeking Alpha
Thursday, June 2, 2011 - 10:28am
tags:
Vical, Allovectin-7
Bristol-Myers, Roche team up on melanoma drugs
Yahoo/AP
Thursday, June 2, 2011 - 10:26am
tags:
Roche, Bristol-Myers Squibb, melanoma, Yervoy, vermurafenib
J&J’s Prostate Drug Extends Life as Spur to $5 Billion Market
Bloomberg
Thursday, June 2, 2011 - 10:25am
tags:
prostate cancer, JNJ, Zytiga
Zalicus in Novartis's Sweet Spot Signals More Upside
Seeking Alpha
Wednesday, June 1, 2011 - 6:48pm
tags:
Zalicus, Novartis, ASCO, oncology
Novartis to showcase blockbuster cancer drug strategy at ASCO
Fierce Biotech
Wednesday, June 1, 2011 - 6:44pm
tags:
Novartis, ASCO, JAK inhibitors, Incyte
Sanofi plans to shrink, restructure Genzyme
Fierce Pharma
Wednesday, June 1, 2011 - 6:41pm
tags:
Sanofi, Genzyme, reorganization
Orexigen shares jump on new hope for Contrave
Yahoo/AP
Wednesday, June 1, 2011 - 6:39pm
tags:
Contrave, Orexigen, obesity
FDA speeds up new review of Alexion's Soliris
Yahoo/AP
Wednesday, June 1, 2011 - 6:36pm
tags:
Alexia, Soliris
Johnson & Johnson Hid Antibiotic Levaquin Risk, Lawyer Says
Bloomberg
Wednesday, June 1, 2011 - 12:38pm
tags:
Levaquin, JNJ, antibiotics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.